Delivery Order SPE2DR25D2011-SPE2DR26FADGD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Briviact 75 mg tablets (60-count units) under a firm fixed price contract valued at $2,124.38, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December...
- The Defense Logistics Agency awarded a $1,544.72 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 100 mg tablets (60 count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,002.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Briviact 100 mg tablets (60-unit quantity). This is a non-set-aside competitive award with an ultimate completion date of October 21, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $285,550 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 20, 2025, for Briviact 75 mg tablets (60-count packages) valued at $2,183.46. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of October 21, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,451.23 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,100.94 on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count packages) under a firm fixed-price contract with no set-aside designation. The award is supported by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense, with an ultimate completion date of August 5, 2025. This delivery order...
- The Defense Logistics Agency awarded a $3,574.48 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract was awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,484.01 delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Briviact 75 mg tablets (60-count). The contract utilizes firm fixed pricing with a non-competitive set-aside and is scheduled for completion by October 20, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADGDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Briviact 75 mg tablets (60-count units) under a firm fixed-price contract valued at $2,224.71. This non-set-aside award represents a child delivery order issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The delivery order will be performed at AmerisourceBergen's Conshohocken facility with an ultimate completion date of November 4, 2025. As a leading pharmaceutical supplier to the Defense Logistics Agency, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurements through firm fixed-price delivery orders, enabling the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to access critical pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/3/25 |